#hepatitis-b

#hepatitis-b

Newborn hepatitis B vaccination prevents early-life infections that often lead to chronic disease, liver cancer, cirrhosis, and death; delaying until adolescence increases risk.

US changes to vaccine and medicine recommendations risk undermining global health messaging and conflict with established pediatric guidance on hepatitis B and acetaminophen use.

ACIP voted against recommending the combined MMRV shot for children under four and supported universal hepatitis B testing for pregnant people amid contentious committee changes.

CDC vaccine recommendations face political pressure, with imminent changes to the childhood schedule and potential weakening of newborn Hepatitis B vaccination.